Release Date: 29/06/22 19:20 Summary: Estimated Distribution Announcement Price Sensitive: Yes Download Document 226.9KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans